Disease Programs News Today

Lexeo announces $95.0M equity financing, which in addition to 2023 year-end cash and cash equivalents of $121.5M, extends runway to fund operations into 2027 Reports frataxin protein expression data...

HOOKIPA to prioritize clinical development of HB-200 for the treatment of HPV16+ head and neck cancers and Gilead-partnered programs in infectious disease HOOKIPA will regain global development...

HOOKIPA to prioritize clinical development of HB-200 for the treatment of HPV16+ head and neck cancers and Gilead-partnered programs in infectious...

Services provided by the University of Georgia’s Cognitive Aging Research and Education Center (CARE) and the Athens Community Council on Aging (ACCA) are preparing to expand, seeking to address the

Completed enrollment of the LEAD Phase 1/2 clinical trial of LX1001 for the treatment of APOE4-associated Alzheimer’s disease

Trial sees success with single dose of prophylactic rifapentine for household contacts

AC Immune to Present Progress of Alzheimer’s Disease Programs targeting Abeta and Tau at the 15th CTAD Conference Next generation SupraAntigen® liposomal vaccine platform augments immunization against pathological targets of Alzheimer’s diseaseNew data on anti-phospho-Tau vaccines confirm safety...

By NATALIA RODRÍGUEZ MEDINA/DEMOCRAT AND CHRONICLE • 10 hours ago Karol Suárez, 41, knows how hard it can be for some people to get the mental-health care they need. Sometimes it even requires family members to lie to their loved ones. In 2019, Suárez was at a mental health conference to talk about her work as a community health worker -- or health promoter -- for the Chicago-based Latino Alzheimers and Memory Disorders Alliance (LAMDA), which supports Latinos with cogni...